Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 35 | Bawel Zachary WDirector | Open-market purchase | BUY | $17K 344 sh | Oct 16, 2026 |
| 32 | Foff Erin PennockChief Medical Officer | Open-market sale | SELL | $124K 15.4K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 32 | Seger Andrew MDirector | Open-market purchase | BUY | $100 2 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 28 | Marinaro MichaelEVP, Pres MedSurg and Americas | Open-market sale · 10b5-1 plan | SELL | $1.00M 10.4K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 27 | Stirrup AllisonChief Human Resources Officer | Open-market sale · 10b5-1 plan | SELL | $207K 922 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 26 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $303K 3,083 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 25 | Jergensen JoshuaPresident & COO | Open-market sale · 10b5-1 plan | SELL | $1.78M 40.0K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 23 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $128K 1,276 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 23 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $100K 980 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Pittas Aristeidis PDirector | Open-market purchase | BUY | $14K 300 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Costanzo Brian J.Chief Financial Officer | Other acquisition or disposition | J | $3,000 2 sh | Oct 16, 2026 traded Sep 30, 2026 |
| 22 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.16M 24.8K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Boylston LukeChief Accounting Officer | Tax withholding | F | $134K 19.7K sh | Oct 16, 2026 traded Oct 13, 2026 |
| 22 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.68M 77.5K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Murphy Kevin MichaelDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $399K 1,776 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 22 | Arison GeorgeDirector, CHIEF EXECUTIVE OFFICER | Tax withholding | F | $2.87M 190.8K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 22 | Pittas Aristeidis PDirector | Open-market purchase | BUY | $14K 300 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Olson Peter AChief Scientific Officer | Grant or award | A | — 19.5K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Lowenkron Melissa BChief Brand Officer | Grant or award | A | — 65.2K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Paradise AndrewDirector, Chief Executive Officer, 10% Owner | Option exercise | M | — 142.9K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Tubman Casey JGROUP PRESIDENT | Grant or award | A | — 16.7K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 21 | Webster AaronEVP, Global Chief Risk Officer | Option exercise | M | — 5,900 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Webster AaronEVP, Global Chief Risk Officer | Option exercise | M | — 2,622 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 21 | Josephson NeilChief Medical Officer | Grant or award | A | — 31.0K sh | Oct 16, 2026 traded Oct 14, 2026 |
| 20 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 133 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 20 | Natali ChrisSVP, Chief Accounting Officer | Tax withholding | F | $72K 1,291 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 20 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,900 100 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 19 | Schlicher JakeChief Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $70K 314 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | Hopman MarkChief Commercial Officer | Open-market sale | SELL | $13K 775 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 19 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $186K 1,861 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | Graham Ian T.See Remarks | Open-market sale · 10b5-1 plan | SELL | $53K 238 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | Britt Christopher RDirector, Chief Executive Officer | Tax withholding | F | $1.96M 67.4K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | Ghazi SassineDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $6.76M 14.6K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | Murphy Kevin MichaelDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $151K 685 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 19 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $403K 8,462 sh | Oct 16, 2026 traded Oct 16, 2026 |
| 19 | Thees William T. JrChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $79K 353 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 19 | King Ryan ADirector, Co-Founder | Tax withholding | F | $1.08M 37.2K sh | Oct 16, 2026 traded Oct 15, 2026 |
| 18 | Chen Sean ChihhsiangPresident and COO | Open-market sale · 10b5-1 plan | SELL | $378K 7,539 sh | Oct 16, 2026 traded Oct 14, 2026 |
| 17 | Natali ChrisSVP, Chief Accounting Officer | Option exercise | M | — 2,727 sh | Oct 16, 2026 traded Oct 15, 2026 |
| 17 | Talluri Rajendra KDirector, CEO | Grant or award | A | — 28.4K sh | Oct 16, 2026 traded Oct 14, 2026 |